Dear All,
In order to account for uncertainty in estimated parameters when running a
simulation, a natural approach would be running multiple simulations for
different parameter vectors which are drawn from the (theoretical, asymptotic)
distribution of the estimator (i.e. normal with mean THETA
Dear all,
I wanted to reach out to you today to discuss a few open positions with one of
our clients, a top, global pharmaceutical company. Below is a brief description.
Associate Director / Sr. Associate Director
Job Description
Associate Director and Sr. Associate Director for a global pharma
Dear Sven
If you don't assume the covariance between THETA(1) and THETA(2) to be zero but
use the estimated covariance value, you do let the data speak. A problem in
this respect is that publications never give such values even if it of course
is possible. With online access to model code and o
Dear Colleagues,
We are happy to announce the
1st European Training Course on Pharmacokinetics and Pharmacodynamics of
Protein Therapeutics - Principles and Pharmacometric Approaches
that will be held in Lausanne, Switzerland on March 21-23, 2016.
The 3-day course is a shortened version of the
